Page 2 - Last Accessed News Today

- TAKHZYRO® is the First Routine Prevention Treatment of HAE Approved in the EU for Patients Under the Age...

Results announced today in a multi-country GSK-commissioned and funded survey conducted by Ipsos show that parents are less knowledgeable about meningitis compared to some other childhood infectious diseases. The aim of the survey was to gain an understanding of meningitis awareness and any potential gaps in ...

New multi-country survey finds 93% of parents couldnt identify all three of the most common meningitis symptoms.1 While 88% considered meningitis to be a serious...

ZURICH, Sept. 22, 2023 /PRNewswire/ -- Takeda (TSE:4502) (NYSE:TAK) today announced the European Medicines...

Screening programmes remain the most powerful tool to reduce cervical cancer rates in the near term, but there is a concerning decline in participation in some...

Metadata: the data about the data, the extra goodies, the secret bits that tell you the when, where, and how of a file. Everyone who has used eDiscovery for a while knows some metadata...

No More Excuses, ADB! Prioritize Sustainable Solutions and Stop Funding Harmful Waste-to-Energy (WtE) Incinerators 02 May 2023 -  The Asian Development

Patients treated with investigational bimekizumab, an IL-17A and IL-17F inhibitor, achieved statistically significant and clinically meaningful improvements...

/PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that Annals of the Rheumatic Diseases has published 24-week results from the Phase 3...

CRYSVITA is the first approved biologic treatment in the EU for patients with TIO who cannot undergo surgical removal of tumours Kyowa Kirin Co., Ltd. (TSE: 4151, Kyowa Kirin) today announced that